Home
Alembic Pharmaceuticals Ltd Share Price History
Alembic Pharmaceuticals Ltd
NSE : 21 Feb, 2025
803.4-10.9 (-1.3%)
Prev Close
814.3
Open Price
812.7
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
45573
Today's High / Low
821.0 / 800.0
52 WK High / Low
1303.9 / 788.2
Market Price of Alembic Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 21.59 |
| YoY Gr. | - |
| Net Profit (Cr.) | 407 |
| BVPS | 100.92 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 36.75 |
| Op. Profit Mgn % | 19.66 |
| Net Profit Mgn % | 13.65 |
| Debt to Equity % | 0.24 |
Latest Shareholding
Promoters Holdings Over Time
About Alembic Pharmaceuticals Ltd
- Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world.
- The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
- As per the scheme of arrangement, the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.
Popular Search
FAQs for Alembic Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Alembic Pharmaceuticals Ltd's share price history?
Key events that impact Alembic Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Alembic Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Alembic Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Alembic Pharmaceuticals Ltd?
Dividends can influence Alembic Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Alembic Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Alembic Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Alembic Pharmaceuticals Ltd’s share price history?
To understand Alembic Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
